ArticleInternational journal of hematology2020
Phase I study of duvelisib in Japanese patients with relapsed or refractory lymphoma.
Koji Izutsu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it